http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy debutripathy Blog en-us Mon, 20 May 2013 23:52:21 -0700 Fri, 08 Mar 2013 07:17:00 -0700 BlogCFC http://blogs.law.harvard.edu/tech/rss moderator@curetoday.com (moderator) moderator@curetoday.com (moderator) moderator@curetoday.com http://www.curetoday.com/assets/images/placeholder.gif http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy no http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2013/3/8/Is-advanced-breast-cancer-really-increasing-in-younger-women A high-profile article was published recently showing a small but statistically significant increase in the rate younger women, aged 25-39 diagnosed with breast cancer with distant metastasis. Published in the Journal of the American Medical Associat... Young adults Breast cancer Fri, 08 Mar 2013 07:17:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2013/3/8/Is-advanced-breast-cancer-really-increasing-in-younger-women http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2013/2/18/Personalized-medicine-and-what-it-means Personalized cancer medicine has become a major buzzword as of late, but what does it really mean? Everyone defines it differently, so the bird's eye view of this term would be as encompassing as possible. On one level, it means that every patie... Featured Mon, 18 Feb 2013 12:05:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2013/2/18/Personalized-medicine-and-what-it-means http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2013/1/24/Small-gains-in-pancreatic-cancers-add-up Two small steps forward emanated from the ASCO Gastrointestinal Cancers Symposium going on this week, and they both raise the difficult issue of very small gains and what they mean. In patients with advanced pancreatic cancer, the addition of the... Treatment Thu, 24 Jan 2013 07:00:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2013/1/24/Small-gains-in-pancreatic-cancers-add-up http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/12/11/One-year-of-Herceptin-optimal-for-HER2positive-breast-cancer On one of the final days of SABCS there was some interesting updates to Herceptin. Seven years ago, the original data on Herceptin in early-stage breast cancer was presented. This year, there was an interesting update to the U.S. trial that was p... SABCS2012 Tue, 11 Dec 2012 11:00:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/12/11/One-year-of-Herceptin-optimal-for-HER2positive-breast-cancer http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/12/7/How-do-we-treat-local-recurrence-of-breast-cancer On the third day of SABCS, one study gave us another answer on how to treat local recurrence of breast cancer. We also learn more about the role of radiation in breast cancer treatment. View the video below to get more insight into these breast c... SABCS2012 Breast cancer Fri, 07 Dec 2012 20:52:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/12/7/How-do-we-treat-local-recurrence-of-breast-cancer http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/12/6/Study-confirms-higher-dose-of-Falsodex-needed In the area of hormonal therapy yesterday, there was a trial for metastatic breast cancer patients who were receiving Faslodex. This drug has been shown to delay progression and is now a standard of care. Unfortunately, we haven't really nailed down ... SABCS2012 Breast cancer Thu, 06 Dec 2012 13:30:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/12/6/Study-confirms-higher-dose-of-Falsodex-needed http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/12/6/Should-women-take-10-years-of-tamoxifen-to-prevent-breast-cancer-recurrence At this year's San Antonio Breast Cancer Symposium, a long-term study of tamoxifen was announced. This study, called ATLAS, looked at women who took more than five years of tamoxifen after breast cancer. There has been a lot of interest in whether mo... SABCS2012 Breast cancer Thu, 06 Dec 2012 13:19:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/12/6/Should-women-take-10-years-of-tamoxifen-to-prevent-breast-cancer-recurrence http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/10/29/Do-you-understand-the-goal-of-your-cancer-treatment The New England Journal of Medicine tends to publish larger and higher impact studies that will affect standards of care, but they also will print eye-opening studies that tell us something unexpected and give us pause for thought. A very importa... Lung cancer Featured Colorectal cancer Mon, 29 Oct 2012 12:58:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/10/29/Do-you-understand-the-goal-of-your-cancer-treatment http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/9/4/Personalized-medicine-in-the-genomic-age-of-breast-cancer We're not going to find one drug to treat everyone. That's why molecular medicine, or personalized medicine, has become so important in treating breast cancer, in fact - all cancers. And like all cancers, there will not be a one-size fits all tre... Breast cancer Tue, 04 Sep 2012 11:20:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/9/4/Personalized-medicine-in-the-genomic-age-of-breast-cancer http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/8/28/Are-new-therapies-in-ERpositive-breast-cancer-just-the-tip-of-the-iceberg New therapies for breast cancer are now being based on older therapies such as those that are involved in estrogen blockade. As we understand more about this type of breast cancer, we learn that many of the growth pathways are in fact vast networks. ... Breast cancer Tue, 28 Aug 2012 07:32:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/8/28/Are-new-therapies-in-ERpositive-breast-cancer-just-the-tip-of-the-iceberg http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/8/21/Embarking-on-a-program-for-young-adult-cancer-patients Cancer does not affect everyone equally. They type and extent of cancer matters, of course, but so does the nature of the individual. One of the biggest differentiators is age, especially those who are in the adolescent and young adult age, whic... Young adults Tue, 21 Aug 2012 11:30:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/8/21/Embarking-on-a-program-for-young-adult-cancer-patients http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/6/29/Affordable-Cancer-Act-upheld-by-Supreme-Court It was a complicated decision – so complicated that a couple of the major news outlets reported incorrectly that the sweeping health care reform law enacted by Congress in 2010 have been struck down by the Supreme Court. In fact, most of this la... News Fri, 29 Jun 2012 12:05:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/6/29/Affordable-Cancer-Act-upheld-by-Supreme-Court http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/6/14/Super-Herceptin So how does T-DM1, an investigational agent that attaches Herceptin to a toxic drug, stand up when tested against the current treatment for cancer already progressing on Herceptin? Well, it's been quite a busy time at ASCO, a lot of advancements o... Featured ASCO Thu, 14 Jun 2012 10:30:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/6/14/Super-Herceptin http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/6/5/New-findings-on-chemotherapy-for-breast-cancer Even in the age of biologically targeted drugs, chemotherapy still remains what is known as the "backbone" of therapy in many situations. Chemotherapy is commonly used with biological agents both in early-stage breast cancer to lower the chance of re... ASCO Breast cancer Tue, 05 Jun 2012 10:40:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/6/5/New-findings-on-chemotherapy-for-breast-cancer http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2012/6/2/Another-breakthrough-in-immunotherapy We are still not curing advanced cancers with immunologic therapy, but an important step forward was announced today at the annual meeting of the American Society of Clinical Oncology (ASCO). Both at ASCO and simultaneously published online in the Ne... ASCO Sat, 02 Jun 2012 21:36:00 -0700 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2012/6/2/Another-breakthrough-in-immunotherapy